UDILIV 300 MG (Ursodeoxycholic Acid (300mg))

Udiliv 300 mg Tablet is indicated for the dissolution of specific types of gallstones and the prevention of new stone formation. It functions by breaking down cholesterol that has formed into stones within the gallbladder, facilitating their dissolution. Additionally, it is utilized in the management of primary biliary cirrhosis, a liver condition. The recommended administration of Udiliv 300 mg involves swallowing the tablet whole with water or milk after meals. The dosage prescribed will vary based on the specific condition being treated as well as individual health factors. It is essential to adhere to the prescribed regimen consistently to achieve optimal results, and one should continue usage for the duration recommended by the healthcare provider, which may extend over several months, even in the absence of noticeable symptoms. Prior to commencing treatment, it is important to inform the healthcare provider about any existing conditions such as inflammation of the gallbladder or bile ducts, episodes of severe abdominal cramping, hemoptysis (coughing up blood), or rapid weight gain. The medication may interact with other treatments, thus all concurrent medications should be disclosed to the healthcare provider. Women who are pregnant or breastfeeding should seek medical advice before starting Udiliv 300 mg to ensure its safety.